Tag: nasdaq:vrtx
November 24, 2019
5 Top NASDAQ Biotech and Pharma Stocks: Fulcrum Climbs 73 Percent
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
November 19, 2019
CRISPR and Vertex Release Positive Gene-editing Results
This is the first time CRISPR/Cas9 gene-editing technology has been used in human trials to treat genetic diseases. November 12, 2019
Vertex Announces Northern Ireland Offer Accepted for Cystic Fibrosis Treatments
The Regional Pharmaceutical Procurement Service in Northern Ireland has accepted an offer for cystic fibrosis treatments.
September 25, 2019
AzurRx BioPharma Dips on Phase 2 Trial Results for MS1819
Shares of the company tumbled more than 20 percent on Wednesday following the release of Phase 2 trial results for...
May 28, 2019
8 Small Biotech ETFs
Want to invest in small biotech ETFs? Here we profile eight that life science investors may want to look into.
December 13, 2018
Pharma Trends 2018: Drug Pricing Takes Center Stage
Knowing what pharma trends influenced the market this year may be key for new and ongoing investing opportunities.
November 29, 2018